Second, the S&P 500 just invalidated the move above the very round (so, important from the psychological point of view) 6,000 ...

Every year for Black Friday Cyber Monday (BFCM), we put together a real-time visualization of purchases made through ...

Gerard Westendorp has a real knack for geometry, and here is his answer. Here is Thurston’s procedure. First draw the lattice of Eisenstein integers in the complex plane: ...

In the evolving landscape of data management, Sachin Gupta explores the remarkable advancements made by integrating machine learning (ML) with database management systems (DBMS). His work sheds light ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...

So when a business like Vertex Pharmaceuticals (NASDAQ: VRTX) releases some new data on a potential blockbuster that could be just a few months away from being approved for sale, it's a big ...

Irvine-based In-N-Out Burger is close to opening four new restaurants in Southern California. The fast-food chain has listed locations in Anaheim, Carson, Sylmar and Oxnard as “Opening Soon ...

Vertex has reported phase 3 data on its near-approval pain drug candidate suzetrigine, shedding light on how the non-opioid painkiller combines with ibuprofen and why the prospect failed to match ...

Vertex Pharmaceuticals has a virtual monopoly in treating cystic fibrosis, having created and brought to market a function cure for 90% of the CF population. Their pipeline outside of CF has shown ...

BMO Capital Markets analyst Evan Seigerman in a note to investors said the late-stage data for Vertex’s experimental non-opioid pain medication “reaffirms our confidence in the strength of suzetrigine ...